All Stories

  1. Added Benefit of Raxibacumab to Antibiotic Treatment of Inhalational Anthrax

    Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

    Mr Alfred E Corey, Mr Alfred E Corey

  2. Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/ Raxibacumab-Treated New Zealand White Rabbits

    Article • Toxins, January 2013, MDPI AG

    Mr Alfred E Corey

  3. Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2b

    Article • The Journal of Clinical Pharmacology, April 2012, Wiley

    Mr Alfred E Corey

  4. Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals

    Article • European Journal of Clinical Pharmacology, February 2012, Springer Science + Business Media

    Mr Alfred E Corey

  5. T2008 Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2B

    Article • Gastroenterology, May 2010, Elsevier

    Mr Alfred E Corey

  6. 295 POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE OF ALBINTERFERON ALFA-2B

    Article • Journal of Hepatology, April 2010, Elsevier

    Mr Alfred E Corey

  7. Raxibacumab for the Treatment of Inhalational Anthrax

    Article • New England Journal of Medicine, July 2009, New England Journal of Medicine (NEJM/MMS)

    Mr Alfred E Corey

  8. A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

    Article • Clinical Cancer Research, June 2008, American Association for Cancer Research (AACR)

    Mr Alfred E Corey

  9. Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Receptor-1

    Article • Journal of Clinical Oncology, April 2007, American Society of Clinical Oncology (ASCO)

    Mr Alfred E Corey

  10. Influence of Coadministration on the Pharmacokinetics of Azimilide Dihydrochloride and Digoxin

    Article • The Journal of Clinical Pharmacology, July 2005, Wiley

    Mr Alfred E Corey

  11. 197 A phase I and pharmacokinetic (PK) study of an agonistic, fully human monoclonal antibody, HGS-ETR2, to the TNF-alpha related apoptosis inducing ligand receptor 2 (TRAIL R2) in patients with advanced cancer

    Article • European Journal of Cancer Supplements, September 2004, Elsevier

    Mr Alfred E Corey

  12. 208 HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: results of a phase I trial

    Article • European Journal of Cancer Supplements, September 2004, Elsevier

    Mr Alfred E Corey

  13. Effect of Mild and Moderate Hepatic Impairment on Azimilide Pharmacokinetics Following Single Dose Oral Administration

    Article • Journal of Pharmaceutical Sciences, May 2004, Elsevier

    Mr Alfred E Corey

  14. Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration

    Article • British Journal of Clinical Pharmacology, November 2002, Wiley

    Mr Alfred E Corey

  15. Pharmacokinetics and Pharmacodynamics following Intravenous Doses of Azimilide Dihydrochloride

    Article • The Journal of Clinical Pharmacology, December 1999, Wiley

    Mr Alfred E Corey

  16. Azimilide Pharmacokinetics following Intravenous and Oral Administration of a Solution and Capsule Formulation

    Article • The Journal of Clinical Pharmacology, December 1999, Wiley

    Mr Alfred E Corey

  17. Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing

    Article • Biopharmaceutics & Drug Disposition, March 1999, Wiley

    Mr Alfred E Corey

  18. Effect of Multiple Cilostazol Doses on Single Dose Lovastatin Pharmacokinetics in Healthy Volunteers

    Article • Clinical Pharmacokinetics, January 1999, Springer Science + Business Media

    Mr Alfred E Corey

  19. Azimilide Dihydrochloride, a Novel Antiarrhythmic Agent

    Article • The American Journal of Cardiology, March 1998, Elsevier

    Mr Alfred E Corey

  20. Effect of Age and Gender on Azimilide Pharmacokinetics After a Single Oral Dose of Azimilide Dihydrochloride

    Article • The Journal of Clinical Pharmacology, October 1997, Wiley

    Mr Alfred E Corey